Cardo Medical’s innovative total knee system is the flagship product within its Align 360 platform, which has already received the FDA clearance for its uni-compartmental and patello-femoral systems.
According to the company, all three systems feature a modular approach and common instrumentation system with a new concept designed to deliver simplified, reproducible surgical outcomes. The Align 360 total knee system is planned for commercial release during the second quarter of 2009.
Andrew Brooks, chairman and CEO of Cardo Medical, said: “We are pleased to have achieved this regulatory milestone and are excited to have rounded out our Align 360 platform. Our novel, minimally invasive instrumentation is designed to enable surgeons to achieve superior surgical outcomes. Cardo Medical looks forward to introducing these and other orthopedic design innovations to the US market over the upcoming quarters.”